West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend

West Pharma (WST) Tops Q2 EPS by 17c, Revenues Beat; Raises FY19 EPS/Revenue Guidance

July 25, 2019 6:08 AM EDT

West Pharma (NYSE: WST) reported Q2 EPS of $0.89, $0.17 better than the analyst estimate of $0.72. Revenue for the quarter came in at $469.7 million versus the consensus estimate of $460.4 million.

Net sales of $469.7 million grew 4.9%, organic sales growth was 8.1%; sales from a recent acquisition contributed an additional 20 basis points of growth.Reported-diluted EPS of $0.88 increased 17%.Adjusted-diluted EPS of $0.89 increased 27%.Company is raising full-year 2019 net sales guidance to a new range of between $1.810 billion and $1.825 billion.Company is raising full-year 2019 adjusted-diluted EPS guidance to a... More